{"database": "lobbying", "table": "lobbying_activities", "rows": [[670649, "d19044e0-3fdf-4a9f-bef6-39ec3fa46b66", "Q3", "APOTEX CORP.", 310973, "APOTEX CORP.", 2008, "third_quarter", "PHA", "S. 316, the Preserve Access to Affordable Pharmaceuticals Act\nHR 1902, the Protecting Consumer Access to Generic Drugs Act\nHR 1038, the Access to Life Savings Medicine Act\nHR 5629, the Pathway for Biosimilars Act S. 1695, the Biologics Price Competition and Innovation Act\nHR 5829, the Safeguarding America's Pharmaceuticals Act\nHR 3610, the Food and Drug Import Safety Act, Section 4 User Fees Regarding Drug Safety\nPL 110-85, the Foord and Drug Amendments Act of 2007, Section 914, Citizen Petition and petition for stay of agency action\nPL 110-85, the Food and Drug Amendments Act of 2007. Title VIII, Clinical Trial Databases\nHR 6432, Animal Drug User Fee Amendments of 2008, Section 301, Consideration of Certain Petitions\nCombating anti-generic substitution legislation in the states\nAbbreviated New Drug Application No. 76-396 for calcitonin salmon nasal spray", "HOUSE OF REPRESENTATIVES,SENATE", null, 120000, 0, 0, "2008-10-16T15:11:14-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["670649"], "units": {}, "query_ms": 40.37781397346407, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}